DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Detoxifying enzymes at the cross-roads of inflammation, oxidative stress, and drug hypersensitivity: role of glutathione transferase P1-1 and aldose reductase
9 p.-2 fig, Phase I and II enzymes are involved in the metabolism of endogenous reactive
compounds as well as xenobiotics, including toxicants and drugs. Genotyping studies
have established several drug metabolizing enzymes as markers for risk of drug
hypersensitivity. However, other candidates are emerging that are involved in drug
metabolism but also in the generation of danger or costimulatory signals. Enzymes
such as aldo-keto reductases (AKR) and glutathione transferases (GST) metabolize
prostaglandins and reactive aldehydes with proinflammatory activity, as well as drugs
and/or their reactive metabolites. In addition, their metabolic activity can have important
consequences for the cellular redox status, and impacts the inflammatory response
as well as the balance of inflammatory mediators, which can modulate epigenetic
factors and cooperate or interfere with drug-adduct formation. These enzymes are, in
turn, targets for covalent modification and regulation by oxidative stress, inflammatory
mediators, and drugs. Therefore, they constitute a platform for a complex set
of interactions involving drug metabolism, protein haptenation, modulation of the
inflammatory response, and/or generation of danger signals with implications in drug
hypersensitivity reactions. Moreover, increasing evidence supports their involvement in
allergic processes. Here, we will focus on GSTP1-1 and aldose reductase (AKR1B1) and provide a perspective for their involvement in drug hypersensitivity, This work has been supported by grants SAF2012-36519 from MINECO and SAF-2015-68590-R from MINECO/FEDER and ISCIII RETIC RIRAAF RD12/0013/0008 to DP,and RD12/0013/0002 to J A., Peer reviewed